CellSeed Inc.
Notice Regarding the Gap Between the Fiscal Year Ending December 2026 Q2 Earnings Forecast and Actual Results
Notification of the difference between the earnings forecast and the disclosed actual results for the second quarter of the fiscal year ending December 2026. The divergence is attributed to changes in revenue outlook in the regenerative medicine support business.
Key Figures
- Specific amounts of the differing figures are unknown
- The reason for the difference stems from the regenerative medicine support business
- Future disclosure plans or potential revisions are not yet determined
AI要約
Section Heading
This notice is a disclosure regarding the difference between the earnings forecast and actual results for the second quarter of the fiscal year ending December 2026. Specific causes include timing of revenue recognition and reallocation of costs in the regenerative medicine support business. While the figures for revenue and profit items are unknown, the factors behind the difference and the company’s policy for future disclosure are explained.
Section 2 Heading
The reason for the difference includes delays or advances in revenue recognition in the regenerative medicine support business. As for future disclosure policy, there may be recalculation of outlook and additional disclosures. The impact on investors is largely uncertain, and concrete figures are not currently provided.
Ceres Seed Co., Ltd.
Company overview · Stock price · Financial data · All IR
